Dynatronics Corporation (DYNT)
USD 0.11
(1.92%)
USD 0.11
(1.92%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 25.94 Million USD | -13.71% |
| 2023 | 30.06 Million USD | -15.16% |
| 2022 | 35.43 Million USD | -9.47% |
| 2021 | 39.14 Million USD | 41.94% |
| 2020 | 27.57 Million USD | -30.42% |
| 2019 | 39.63 Million USD | -5.76% |
| 2018 | 42.05 Million USD | 61.35% |
| 2017 | 26.06 Million USD | 70.66% |
| 2016 | 15.27 Million USD | -20.26% |
| 2015 | 19.15 Million USD | 33.98% |
| 2014 | 14.29 Million USD | -5.36% |
| 2013 | 15.1 Million USD | -1.09% |
| 2012 | 15.27 Million USD | 3.05% |
| 2011 | 14.81 Million USD | -1.8% |
| 2010 | 15.09 Million USD | -11.69% |
| 2009 | 17.08 Million USD | -7.27% |
| 2008 | 18.42 Million USD | -0.75% |
| 2007 | 18.56 Million USD | 27.84% |
| 2006 | 14.52 Million USD | 7.9% |
| 2005 | 13.45 Million USD | -5.7% |
| 2004 | 14.27 Million USD | 12.27% |
| 2003 | 12.71 Million USD | 1.64% |
| 2002 | 12.5 Million USD | -7.76% |
| 2001 | 13.56 Million USD | 7.66% |
| 2000 | 12.59 Million USD | -8.73% |
| 1999 | 13.8 Million USD | 18.97% |
| 1998 | 11.6 Million USD | 20.83% |
| 1997 | 9.6 Million USD | 12.94% |
| 1996 | 8.5 Million USD | 18.06% |
| 1995 | 7.2 Million USD | 0.0% |
| 1994 | 7.2 Million USD | 28.57% |
| 1993 | 5.6 Million USD | 36.59% |
| 1992 | 4.1 Million USD | 13.89% |
| 1991 | 3.6 Million USD | 5.88% |
| 1990 | 3.4 Million USD | -12.82% |
| 1989 | 3.9 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 25.94 Million USD | -6.57% |
| 2024 Q1 | 30.34 Million USD | 0.94% |
| 2024 Q3 | 27.76 Million USD | -5.24% |
| 2024 Q2 | 29.29 Million USD | -3.45% |
| 2023 FY | 30.06 Million USD | -15.16% |
| 2023 Q1 | 34.98 Million USD | -1.28% |
| 2023 Q4 | 30.06 Million USD | -10.1% |
| 2023 Q3 | 33.43 Million USD | -4.42% |
| 2023 Q2 | 34.98 Million USD | 0.01% |
| 2022 Q1 | 39.45 Million USD | 0.81% |
| 2022 Q3 | 37.5 Million USD | -0.46% |
| 2022 Q2 | 37.67 Million USD | -4.52% |
| 2022 FY | 35.43 Million USD | -9.47% |
| 2022 Q4 | 35.43 Million USD | -5.51% |
| 2021 Q2 | 37.55 Million USD | 2.19% |
| 2021 FY | 39.14 Million USD | 41.94% |
| 2021 Q1 | 36.75 Million USD | 33.29% |
| 2021 Q3 | 39.91 Million USD | 6.28% |
| 2021 Q4 | 39.14 Million USD | -1.95% |
| 2020 Q2 | 41.99 Million USD | -1.05% |
| 2020 Q1 | 42.44 Million USD | 7.09% |
| 2020 Q3 | 42.04 Million USD | 0.11% |
| 2020 Q4 | 27.57 Million USD | -34.41% |
| 2020 FY | 27.57 Million USD | -30.42% |
| 2019 Q3 | 39.29 Million USD | 1.66% |
| 2019 Q4 | 39.63 Million USD | 0.86% |
| 2019 FY | 39.63 Million USD | -5.76% |
| 2019 Q1 | 41.03 Million USD | -2.43% |
| 2019 Q2 | 38.65 Million USD | -5.8% |
| 2018 Q4 | 42.05 Million USD | -3.07% |
| 2018 FY | 42.05 Million USD | 61.35% |
| 2018 Q1 | 31.74 Million USD | 21.81% |
| 2018 Q3 | 43.38 Million USD | -4.8% |
| 2018 Q2 | 45.56 Million USD | 43.53% |
| 2017 Q4 | 26.06 Million USD | 47.07% |
| 2017 FY | 26.06 Million USD | 70.66% |
| 2017 Q1 | 15.29 Million USD | 0.16% |
| 2017 Q2 | 16.35 Million USD | 6.94% |
| 2017 Q3 | 17.72 Million USD | 8.33% |
| 2016 Q4 | 15.27 Million USD | -1.9% |
| 2016 FY | 15.27 Million USD | -20.26% |
| 2016 Q3 | 15.56 Million USD | -7.69% |
| 2016 Q2 | 16.86 Million USD | -1.52% |
| 2016 Q1 | 17.12 Million USD | -10.57% |
| 2015 Q3 | 18 Million USD | 1.84% |
| 2015 Q1 | 18.27 Million USD | 27.84% |
| 2015 Q2 | 17.67 Million USD | -3.28% |
| 2015 FY | 19.15 Million USD | 33.98% |
| 2015 Q4 | 19.15 Million USD | 6.39% |
| 2014 Q1 | 14.9 Million USD | -1.35% |
| 2014 Q4 | 14.29 Million USD | -0.82% |
| 2014 Q2 | 15.13 Million USD | 1.58% |
| 2014 Q3 | 14.41 Million USD | -4.77% |
| 2014 FY | 14.29 Million USD | -5.36% |
| 2013 Q2 | 15.36 Million USD | 0.85% |
| 2013 Q4 | 15.1 Million USD | 1.17% |
| 2013 Q3 | 14.93 Million USD | -2.85% |
| 2013 FY | 15.1 Million USD | -1.09% |
| 2013 Q1 | 15.23 Million USD | -0.22% |
| 2012 Q1 | 15.14 Million USD | 2.17% |
| 2012 Q3 | 15.4 Million USD | 2.59% |
| 2012 FY | 15.27 Million USD | 3.05% |
| 2012 Q4 | 15.27 Million USD | -0.85% |
| 2012 Q2 | 15.01 Million USD | -0.84% |
| 2011 FY | 14.81 Million USD | -1.8% |
| 2011 Q4 | 14.81 Million USD | 0.59% |
| 2011 Q3 | 14.73 Million USD | -0.98% |
| 2011 Q2 | 14.87 Million USD | -0.44% |
| 2011 Q1 | 14.94 Million USD | -0.97% |
| 2010 Q1 | 17.41 Million USD | 1.9% |
| 2010 FY | 15.09 Million USD | -11.69% |
| 2010 Q4 | 15.09 Million USD | -9.1% |
| 2010 Q3 | 16.6 Million USD | 0.58% |
| 2010 Q2 | 16.5 Million USD | -5.22% |
| 2009 FY | 17.08 Million USD | -7.27% |
| 2009 Q1 | 18.68 Million USD | 1.37% |
| 2009 Q4 | 17.08 Million USD | -2.61% |
| 2009 Q2 | 19.33 Million USD | 3.49% |
| 2009 Q3 | 17.54 Million USD | -9.25% |
| 2008 Q2 | 26.15 Million USD | 2.94% |
| 2008 Q3 | 25.9 Million USD | -0.97% |
| 2008 FY | 18.42 Million USD | -0.75% |
| 2008 Q4 | 18.42 Million USD | -28.86% |
| 2008 Q1 | 25.4 Million USD | 36.85% |
| 2007 Q1 | 14.52 Million USD | -0.0% |
| 2007 FY | 18.56 Million USD | 27.84% |
| 2007 Q4 | 18.56 Million USD | 27.78% |
| 2007 Q3 | 14.53 Million USD | 2.23% |
| 2007 Q2 | 14.21 Million USD | -2.13% |
| 2006 FY | 14.52 Million USD | 7.9% |
| 2006 Q1 | 13.56 Million USD | 0.77% |
| 2006 Q2 | 14.29 Million USD | 5.4% |
| 2006 Q3 | 15.18 Million USD | 6.19% |
| 2006 Q4 | 14.52 Million USD | -4.34% |
| 2005 Q4 | 13.45 Million USD | -3.61% |
| 2005 FY | 13.45 Million USD | -5.7% |
| 2005 Q1 | 14.18 Million USD | -0.64% |
| 2005 Q2 | 14.04 Million USD | -0.97% |
| 2005 Q3 | 13.96 Million USD | -0.57% |
| 2004 Q3 | 14.33 Million USD | 5.1% |
| 2004 Q2 | 13.64 Million USD | 2.21% |
| 2004 Q1 | 13.34 Million USD | 4.98% |
| 2004 Q4 | 14.27 Million USD | -0.45% |
| 2004 FY | 14.27 Million USD | 12.27% |
| 2003 FY | 12.71 Million USD | 1.64% |
| 2003 Q1 | 12.83 Million USD | 2.59% |
| 2003 Q3 | 12.92 Million USD | 1.93% |
| 2003 Q2 | 12.67 Million USD | -1.2% |
| 2003 Q4 | 12.71 Million USD | -1.63% |
| 2002 Q2 | 13.77 Million USD | -3.81% |
| 2002 FY | 12.5 Million USD | -7.76% |
| 2002 Q4 | 12.5 Million USD | -7.08% |
| 2002 Q3 | 13.46 Million USD | -2.26% |
| 2002 Q1 | 14.31 Million USD | 5.58% |
| 2001 Q3 | 13.32 Million USD | 7.01% |
| 2001 FY | 13.56 Million USD | 7.66% |
| 2001 Q1 | 12.73 Million USD | 1.14% |
| 2001 Q2 | 12.45 Million USD | -2.24% |
| 2001 Q4 | 13.56 Million USD | 1.75% |
| 2000 FY | 12.59 Million USD | -8.73% |
| 2000 Q2 | 13.4 Million USD | -1.47% |
| 2000 Q3 | 12.88 Million USD | -3.87% |
| 2000 Q4 | 12.59 Million USD | -2.22% |
| 2000 Q1 | 13.6 Million USD | -1.45% |
| 1999 Q1 | 14.3 Million USD | 23.28% |
| 1999 Q3 | 13.6 Million USD | -0.73% |
| 1999 Q4 | 13.8 Million USD | 1.47% |
| 1999 Q2 | 13.7 Million USD | -4.2% |
| 1999 FY | 13.8 Million USD | 18.97% |
| 1998 Q2 | 10 Million USD | 5.26% |
| 1998 Q3 | 10.8 Million USD | 8.0% |
| 1998 Q4 | 11.6 Million USD | 7.41% |
| 1998 FY | 11.6 Million USD | 20.83% |
| 1998 Q1 | 9.5 Million USD | -1.04% |
| 1997 Q2 | 8.2 Million USD | -4.65% |
| 1997 Q4 | 9.6 Million USD | 9.09% |
| 1997 FY | 9.6 Million USD | 12.94% |
| 1997 Q1 | 8.6 Million USD | 1.18% |
| 1997 Q3 | 8.8 Million USD | 7.32% |
| 1996 Q3 | 7.5 Million USD | 1.35% |
| 1996 FY | 8.5 Million USD | 18.06% |
| 1996 Q1 | 7.2 Million USD | 0.0% |
| 1996 Q2 | 7.4 Million USD | 2.78% |
| 1996 Q4 | 8.5 Million USD | 13.33% |
| 1995 Q1 | 7.3 Million USD | 1.39% |
| 1995 FY | 7.2 Million USD | 0.0% |
| 1995 Q4 | 7.2 Million USD | 0.0% |
| 1995 Q3 | 7.2 Million USD | 0.0% |
| 1995 Q2 | 7.2 Million USD | -1.37% |
| 1994 Q3 | 7.1 Million USD | -1.39% |
| 1994 Q1 | 6.9 Million USD | 23.21% |
| 1994 Q2 | 7.2 Million USD | 4.35% |
| 1994 Q4 | 7.2 Million USD | 1.41% |
| 1994 FY | 7.2 Million USD | 28.57% |
| 1993 FY | 5.6 Million USD | 36.59% |
| 1993 Q3 | 5 Million USD | 19.05% |
| 1993 Q1 | 3.8 Million USD | -7.32% |
| 1993 Q2 | 4.2 Million USD | 10.53% |
| 1993 Q4 | 5.6 Million USD | 12.0% |
| 1992 Q4 | 4.1 Million USD | 2.5% |
| 1992 Q2 | 3.6 Million USD | 2.86% |
| 1992 FY | 4.1 Million USD | 13.89% |
| 1992 Q1 | 3.5 Million USD | -2.78% |
| 1992 Q3 | 4 Million USD | 11.11% |
| 1991 FY | 3.6 Million USD | 5.88% |
| 1991 Q2 | 3.4 Million USD | -2.86% |
| 1991 Q1 | 3.5 Million USD | 2.94% |
| 1991 Q3 | 3.7 Million USD | 8.82% |
| 1991 Q4 | 3.6 Million USD | -2.7% |
| 1990 Q3 | 3.4 Million USD | 0.0% |
| 1990 FY | 3.4 Million USD | -12.82% |
| 1990 Q4 | 3.4 Million USD | 0.0% |
| 1989 Q4 | 3.9 Million USD | 0.0% |
| 1989 FY | 3.9 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 17.297% |
| BrainsWay Ltd. | 62.97 Million USD | 58.806% |
| Cerus Corporation | 197.74 Million USD | 86.882% |
| Envoy Medical, Inc. | 7.64 Million USD | -239.536% |
| electroCore, Inc. | 16.38 Million USD | -58.3% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -237.241% |
| IceCure Medical Ltd | 16.41 Million USD | -58.078% |
| Inogen, Inc. | 326.19 Million USD | 92.048% |
| OrthoPediatrics Corp. | 449.58 Million USD | 94.23% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 4.875% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -56.466% |
| MaxCyte, Inc. | 268.27 Million USD | 90.331% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -220.36% |
| Nexalin Technology, Inc. | 3.63 Million USD | -614.239% |
| Orthofix Medical Inc. | 925.31 Million USD | 97.197% |
| PAVmed Inc | 33.11 Million USD | 21.675% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 81.917% |
| RxSight, Inc. | 182.55 Million USD | 85.79% |
| Sight Sciences, Inc. | 166.65 Million USD | 84.434% |
| SI-BONE, Inc. | 230.42 Million USD | 88.742% |
| TELA Bio, Inc. | 78.04 Million USD | 66.763% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 89.702% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -141.757% |
| Acutus Medical, Inc. | 53.96 Million USD | 51.926% |
| Talis Biomedical Corporation | 98.34 Million USD | 73.622% |
| Spectral AI, Inc. | 10.69 Million USD | -142.617% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 88.136% |
| CVRx, Inc. | 115.22 Million USD | 77.488% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 55.779% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -732.695% |
| Bioventus Inc. | 810.91 Million USD | 96.801% |
| Venus Concept Inc. | 93.65 Million USD | 72.302% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -0.838% |
| LivaNova PLC | 2.42 Billion USD | 98.932% |
| 908 Devices Inc. | 202.98 Million USD | 87.22% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 96.778% |
| Nemaura Medical Inc. | 14.56 Million USD | -78.124% |
| NeuroPace, Inc. | 107.65 Million USD | 75.903% |
| LENSAR, Inc. | 69.58 Million USD | 62.721% |
| Apyx Medical Corporation | 79.24 Million USD | 67.263% |
| Cutera, Inc. | 346.29 Million USD | 92.509% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 38.26% |
| BioSig Technologies, Inc. | 1.79 Million USD | -1342.745% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 90.415% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 39.194% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.314% |
| Axonics, Inc. | 719.92 Million USD | 96.397% |
| Outset Medical, Inc. | 313.8 Million USD | 91.733% |
| IRIDEX Corporation | 34.43 Million USD | 24.67% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 93.59% |
| IRadimed Corporation | 92.15 Million USD | 71.852% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -393.73% |
| INVO Bioscience, Inc. | 20.88 Million USD | -24.19% |
| Telesis Bio, Inc. | 70.41 Million USD | 63.158% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 83.167% |
| Varex Imaging Corporation | 1.24 Billion USD | 97.924% |
| Quipt Home Medical Corp. | 247.4 Million USD | 89.515% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -178.631% |
| Pulmonx Corporation | 178.95 Million USD | 85.504% |
| Modular Medical, Inc. | 13.8 Million USD | -87.88% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -141.825% |
| Semler Scientific, Inc. | 78.06 Million USD | 66.771% |
| InMode Ltd. | 863.28 Million USD | 96.995% |
| Bruker Corporation | 4.24 Billion USD | 99.39% |
| Cytosorbents Corporation | 53.26 Million USD | 51.295% |
| DexCom, Inc. | 6.26 Billion USD | 99.586% |
| Align Technology, Inc. | 6.08 Billion USD | 99.574% |
| Viveve Medical, Inc. | 25.91 Million USD | -0.106% |
| ZimVie Inc. | 1.2 Billion USD | 97.848% |
| Movano Inc. | 9.42 Million USD | -175.348% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 94.788% |
| Nexalin Technology, Inc. | 3.63 Million USD | -614.239% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 55.779% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 97.277% |
| Profound Medical Corp. | 43.68 Million USD | 40.621% |
| Insulet Corporation | 2.58 Billion USD | 98.998% |
| enVVeno Medical Corporation | 48.63 Million USD | 46.663% |
| Surmodics, Inc. | 185.73 Million USD | 86.033% |
| iCAD, Inc. | 41.41 Million USD | 37.369% |
| Nuwellis, Inc. | 9.77 Million USD | -165.512% |
| Biotricity, Inc. | 5.94 Million USD | -336.517% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 94.011% |
| Aethlon Medical, Inc. | 8.24 Million USD | -214.584% |
| InspireMD, Inc. | 47.64 Million USD | 45.552% |
| PAVmed Inc. | 33.11 Million USD | 21.675% |
| BIOLASE, Inc. | 35.1 Million USD | 26.097% |
| Beyond Air, Inc. | 56.96 Million USD | 54.459% |
| FONAR Corporation | 214.24 Million USD | 87.892% |
| AxoGen, Inc. | 196.82 Million USD | 86.821% |
| Vivani Medical, Inc. | 45.79 Million USD | 43.358% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 90.783% |
| Inari Medical, Inc. | 674.23 Million USD | 96.153% |
| UFP Technologies, Inc. | 404.13 Million USD | 93.581% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -10.864% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -172.969% |
| Tenon Medical, Inc. | 6.34 Million USD | -308.835% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -175.758% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 74.972% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.438% |
| Sintx Technologies, Inc. | 15.36 Million USD | -68.829% |
| NanoVibronix, Inc. | 6.67 Million USD | -288.681% |
| Quanterix Corporation | 425.01 Million USD | 93.896% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -178.631% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 51.718% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 98.514% |
| TransMedics Group, Inc. | 706.04 Million USD | 96.326% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 58.95% |
| NeuroMetrix, Inc. | 21.42 Million USD | -21.079% |
| Hyperfine, Inc. | 94.19 Million USD | 72.462% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 90.344% |
| Biomerica, Inc. | 9.25 Million USD | -180.317% |
| Bone Biologics Corporation | 3.73 Million USD | -594.013% |
| AVITA Medical, Inc. | 144.33 Million USD | 82.028% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -432.821% |
| Silk Road Medical, Inc | 265.3 Million USD | 90.223% |